Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Current Deferred Revenue (2018 - 2026)

Viemed Healthcare filings provide 8 years of Current Deferred Revenue readings, the most recent being $7.5 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 12.34% to $7.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.5 million, a 12.34% increase, with the full-year FY2025 number at $7.5 million, up 12.34% from a year prior.
  • Current Deferred Revenue hit $7.5 million in Q4 2025 for Viemed Healthcare, down from $7.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $7.8 million in Q3 2025 to a low of $3.4 million in Q1 2021.
  • Median Current Deferred Revenue over the past 5 years was $6.0 million (2023), compared with a mean of $5.5 million.
  • Biggest five-year swings in Current Deferred Revenue: increased 0.82% in 2021 and later skyrocketed 35.39% in 2023.
  • Viemed Healthcare's Current Deferred Revenue stood at $3.8 million in 2021, then increased by 23.21% to $4.6 million in 2022, then skyrocketed by 34.23% to $6.2 million in 2023, then grew by 7.85% to $6.7 million in 2024, then rose by 12.34% to $7.5 million in 2025.
  • The last three reported values for Current Deferred Revenue were $7.5 million (Q4 2025), $7.8 million (Q3 2025), and $7.2 million (Q2 2025) per Business Quant data.